IRIS
CASALE, Maddalena
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.473
NA - Nord America 3.434
AS - Asia 2.250
SA - Sud America 407
Continente sconosciuto - Info sul continente non disponibili 228
AF - Africa 39
OC - Oceania 1
Totale 11.832
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 3.615
US - Stati Uniti d'America 3.323
SG - Singapore 896
IT - Italia 654
CN - Cina 513
IE - Irlanda 507
BR - Brasile 335
HK - Hong Kong 289
VN - Vietnam 230
GB - Regno Unito 176
DE - Germania 166
KR - Corea 100
UA - Ucraina 95
IN - India 66
CA - Canada 50
GR - Grecia 46
FR - Francia 42
JP - Giappone 38
SE - Svezia 34
FI - Finlandia 33
AR - Argentina 31
AT - Austria 26
TR - Turchia 25
MX - Messico 20
NL - Olanda 19
PK - Pakistan 17
BE - Belgio 13
IQ - Iraq 12
CO - Colombia 11
ID - Indonesia 11
ZA - Sudafrica 11
BD - Bangladesh 10
GT - Guatemala 9
CH - Svizzera 8
CL - Cile 7
DZ - Algeria 7
HN - Honduras 7
PY - Paraguay 7
UZ - Uzbekistan 7
VE - Venezuela 7
EC - Ecuador 6
ES - Italia 6
CR - Costa Rica 5
JO - Giordania 5
KE - Kenya 5
CZ - Repubblica Ceca 4
LB - Libano 4
PL - Polonia 4
PR - Porto Rico 4
PT - Portogallo 4
RO - Romania 4
SV - El Salvador 4
TN - Tunisia 4
EG - Egitto 3
IR - Iran 3
KZ - Kazakistan 3
MA - Marocco 3
RS - Serbia 3
SA - Arabia Saudita 3
SC - Seychelles 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
BG - Bulgaria 2
BS - Bahamas 2
CY - Cipro 2
DO - Repubblica Dominicana 2
GD - Grenada 2
IL - Israele 2
LT - Lituania 2
MK - Macedonia 2
PH - Filippine 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
AU - Australia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GP - Guadalupe 1
HU - Ungheria 1
JM - Giamaica 1
KG - Kirghizistan 1
KW - Kuwait 1
LU - Lussemburgo 1
MD - Moldavia 1
NG - Nigeria 1
NI - Nicaragua 1
TH - Thailandia 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 11.606
Salva come PNG Salva come JPEG
Città #
Moscow 1.301
Dublin 492
Singapore 410
San Jose 390
Santa Clara 327
Hong Kong 286
Ashburn 284
Council Bluffs 245
Chandler 231
Jacksonville 192
Seoul 99
Beijing 97
Ann Arbor 88
Ho Chi Minh City 81
Princeton 81
Hefei 71
Bremen 70
Caserta 69
Naples 67
Roxbury 66
Milan 64
Dallas 58
Hanoi 53
Medford 52
New York 49
Bengaluru 38
The Dalles 37
Woodbridge 35
São Paulo 34
Rome 31
Munich 28
Los Angeles 25
Nanjing 25
Wilmington 25
Des Moines 23
Ercolano 23
Boardman 21
Cambridge 20
Da Nang 18
Miano 18
Grumo Nevano 17
Vienna 17
Napoli 16
North Bergen 14
Atlanta 13
Brussels 13
Haiphong 13
Helsinki 13
Nuremberg 12
Brooklyn 11
Montreal 10
Pescara 10
Phoenix 10
Belo Horizonte 9
Falkenstein 9
Kochi 9
San Francisco 9
San Mateo 9
Boston 8
Chicago 8
Curitiba 8
Houston 8
Johannesburg 8
Pozzuoli 8
Amsterdam 7
Bologna 7
Brasília 7
London 7
Mexico City 7
Nanchang 7
Nocera Inferiore 7
Redwood City 7
Rio de Janeiro 7
Seattle 7
Tashkent 7
Toronto 7
Aversa 6
Fairfield 6
Hải Dương 6
Istanbul 6
Memphis 6
Mountain View 6
Orem 6
Orlando 6
Shanghai 6
Shenyang 6
Tianjin 6
Turku 6
Asunción 5
Biên Hòa 5
Campinas 5
Chennai 5
Denver 5
Elora 5
Guatemala City 5
Kunming 5
Nairobi 5
Salvador 5
San Sebastiano al Vesuvio 5
Stella Cilento 5
Totale 6.102
Salva come PNG Salva come JPEG
Nome #
Effects of germline VHL deficiency on growth, metabolism, and mitochondria 234
Juvenile erythrocytosis in children after liver transplantation: prevalence, risk factors and outcome 224
Cognitive, Brain and Intracranial Artery Involvement in Beta Thalassemia 222
Blood transfusions and adverse acute events: a retrospective study from 214 transfusion-dependent pediatric patients comparing transfused blood components by apheresis or by whole blood 204
Screening for sickle cell disease by point-of-care tests in Italy: pilot study on 1000 at risk children 198
HNF-1β mutation affects PKD2 and SOCS3 expression causing renal cysts and diabetes in MODY5 kindred. 198
Congenital erythrocytosis associated with gain-of-function HIF2A gene mutations and erythropoietin levels in the normal range. 194
Clinical and laboratory features of 103 patients from 42 Italian families with inherited thrombocytopenia derived from the monoallelic Ala156Val mutation of GPIbα (Bolzano mutation) 184
Hereditary hypochromic microcytic anemia associated with loss-of-function DMT1 gene mutations and absence of liver iron overload 183
Endocrine function and bone disease during long-term chelation therapy with deferasirox in patients with β-thalassemia major. 180
Asymptomatic intracranial aneurysms in beta-thalassemia: A three-year follow-up report 173
A Novel 12q13.2-q13.3 Microdeletion Syndrome With Combined Features of Diamond Blackfan Anemia, Pierre Robin Sequence and Klippel Feil Deformity 171
Brain iron content in systemic iron overload: A beta-thalassemia quantitative MRI study 167
Clinical outcome of transfusions with extended red blood cell matching in β-thalassemia patients: A single-center experience 165
Childhood Multiple Endocrine Neoplasia (MEN) Syndromes: Genetics, Clinical Heterogeneity and Modifying Genes 159
Brain functional impairment in beta-thalassaemia: the cognitive profile in Italian neurologically asymptomatic adult patients in comparison to the reported literature 159
Cb2 receptor stimulation and dexamethasone restore the anti-inflammatory and immune-regulatory properties of mesenchymal stromal cells of children with immune thrombocytopenia 156
Acute events in children with sickle cell disease in Italy during the COVID-19 pandemic: useful lessons learned 156
Congenital Dyserythropoietic Anemia Type II: molecular analysis and expression of the SEC23B Gene. 153
BONE MINERAL DENSITY IMPROVEMENT IN PATIENTS WITH THALASSEMIA MAJOR ON LONG-TERM CHELATION THERAPY WITH DEFERASIROX 152
No evidence of increased cerebrovascular involvement in adult neurologically-asymptomatic β-Thalassaemia. A multicentre multimodal magnetic resonance study 150
Association of immune thrombocytopenia and celiac disease in children: A retrospective case control study 149
An Educational Study Promoting the Delivery of Transcranial Doppler Ultrasound Screening in Paediatric Sickle Cell Disease: A European Multi-Centre Perspective 148
Transient erythroblastopenia of childhood after COVID-19 infection: a case report 147
Risk factors for endocrine complications in transfusion-dependent thalassemia patients on chelation therapy with deferasirox: a risk assessment study from a multicentre nation-wide cohort 146
[The Management of Endocrine Complications in Patients with Haemoglobinopathies: Good Clinical Practice of the Italian Society of Thalassemia and Haemoglobinopathies (SITE).] 143
National systematic approach to the management of asplenia: the set up of the Italian Network on Asplenia 138
Headache in beta-thalassemia: An Italian multicenter clinical, conventional MRI and MR-angiography case-control study 138
Absence of blood donors’ anti-SARS-CoV-2 antibodies in pre-storage leukoreduced red blood cell units indicates no role of passive immunity for blood recipients 137
Characterisation of transfusion-dependent prediabetes using continuous glucose monitoring: The Haemoglycare study 136
Long-term improvement in cardiac magnetic resonance in β-thalassemia major patients treated with deferasirox extends to patients with abnormal baseline cardiac function 136
Access to emergency department for acute events and identification of sickle cell disease in refugees. 136
Association between serum ferritin and liver iron concentration with cardiac iron in pediatric thalassemia major patients 132
CB2 and TRPV1 receptors in inflammatory state of macrophages from sickle cell anemia pediatric/young adults 130
Italian patients with hemoglobinopathies exhibit a 5-fold increase in age-standardized lethality due to SARS-CoV-2 infection 129
Clinical and molecular spectrum of glucose-6-phosphate isomerase deficiency. Report of 12 new cases 124
Long-term efficacy of deferasirox for cardiac siderosis in thalassemia major 123
Tricuspid-valve regurgitant jet velocity as a risk factor for death in β-Thalassemia. 120
Response to measles, mumps and rubella (Mmr) vaccine in transfusion-dependent patients 118
Underlying disease is the main risk factor in post-splenectomy complication risk: Data from a national database 117
Rubrica a cura di luciano de seta quando il saturimetro mente… 117
Predicting factors for liver iron overload at the first magnetic resonance in children with thalassaemia major 116
Recommendations for the management of acute immune thrombocytopenia in children. A Consensus Conference from the Italian Association of Pediatric Hematology and Oncology 115
Deferasirox: la chelazione ottimale nelle anemie trasfusione-dipendenti 114
Iron chelating properties of Eltrombopag: Investigating its role in thalassemia-induced osteoporosis 113
Management of the risk for severe infections in children with asplenia: Recommendations from the Italian Network of Asplenia 113
Mutations in ANKRD26 are responsible for a frequent form of inherited thrombocytopenia: Analysis of 78 patients from 21 families 112
Organizing national responses for rare blood disorders: The Italian experience with sickle cell disease in childhood 110
Long term efficacy of iron chelation therapy with deferasirox on endocrine function in thalassemia major 110
Longitudinal Prospective MRI Study in Pediatric Patients With Thalassemia Major 110
Life-Threatening Drug-Induced Liver Injury in a Patient with β-Thalassemia Major and Severe Iron Overload on Polypharmacy. 110
Acute chest syndrome in children with sickle cell disease: Data from a national AIEOP cohort identify priority areas of intervention in a hub-and-spoke system 108
Splenectomy for hereditary spherocytosis: complete, partial or not at all? 107
Hb Vanvitelli: A new unstable α-globin chain variant causes undiagnosed chronic haemolytic anaemia when co-inherited with deletion − α3.7. 107
Hydroxyurea prescription, availability and use for children with sickle cell disease in Italy: Results of a National Multicenter survey. 106
Extramedullary haematopoiesis correlates with genotype and absence of cardiac iron overload in polytransfused adults with thalassaemia 105
Second-line therapy in paediatric warm autoimmune haemolytic anaemia. Guidelines from the Associazione Italiana Onco-Ematologia Pediatrica (AIEOP) 105
Familial neurohypophyseal diabetes insipidus in 13 kindreds and 2 novel mutations in the vasopressin gene 105
HbS/β+ thalassemia: Really a mild disease? A National survey from the AIEOP Sickle Cell Disease Study Group with genotype-phenotype correlation 105
Red blood cell alloimmunisation in transfusion-dependent thalassaemia: A systematic review 104
No increased cerebrovascular involvement in adult beta-thalassemia by advanced MRI analyses 104
Thyroid Nodule Surveillance in Transfusion-Dependent Thalassemia: A Comparative Ultrasonographic Study 103
Nineteen-month-old girl with persistent fever 103
Current challenges in the management of patients with sickle cell disease - A report of the Italian experience 103
Prospective MRI study in pediatric thalassemia major (TM) patients in the MIOT network: a tool to strengthen medical decisions 102
Thalassemia-Associated mixed hypogonadism (TAMH): unraveling a unique endocrine pattern and its impact on cardiovascular risk 101
Multiparametric Cardiac Magnetic Resonance Survey in Children With Thalassemia Major: A Multicenter Study 101
Long‐term outcomes of avascular necrosis in sickle cell disease using joint‐specific patient‐reported outcome measures: Results from a multicentre study 98
Effect of splenectomy on iron balance in patients with β-thalassemia major: a long-term follow-up 98
White matter volume changes in adult beta-thalassemia: Negligible and unrelated to anemia and cognitive performances 98
Selecting β-thalassemia Patients for Gene Therapy: A Decision-making Algorithm 97
Reply to "Hepatocellular carcinoma in thalassemia and other hemoglobinopathies" 96
Myocardial fibrosis by CMR LGE in a large cohort of pediatric thalassemia major patients 96
Disease burden and quality of life of in children with sickle cell disease in Italy: time to be considered a priority 96
Incidence of cancer and related deaths in hemoglobinopathies: A follow-up of 4631 patients between 1970 and 2021 94
Nephrolithiasis in patients exposed to deferasirox and desferioxamine: probably an age-linked event with different effects on some renal parameters 94
Impairment of Innate Immunity and Depletion of Vaccine‐Induced Memory B and T Cells in the Absence of the Spleen 93
Prospective CMR Survey in Children With Thalassemia Major: Insights From a National Network 93
Transfusional Approach in Multi-Ethnic Sickle Cell Patients: Real-World Practice Data From a Multicenter Survey in Italy 93
Prevalence and mortality trends of hemoglobinopathies in Italy: a nationwide study 92
Subarachnoid haemorrhage and cerebral vasculopathy in a child with sickle cell anaemia 92
Good Clinical Practice of the Italian Society of Thalassemia and Haemoglobinopathies (SITE) for the Management of Endocrine Complications in Patients with Haemoglobinopathies 92
Thalassaemia is paradoxically associated with a reduced risk of in-hospital complications and mortality in COVID-19: Data from an international registry 90
Premature aging of the immune system affects the response to SARS-CoV-2 mRNA vaccine in β-thalassemia: role of an additional dose 88
Long-term treatment with deferiprone enhances left ventricular ejection function when compared to deferoxamine in patients with thalassemia major 88
Early splenectomy in sickle cell disease: another piece of the puzzle 86
Mortality in β-thalassemia patients with confirmed pulmonary arterial hypertension on right heart catheterization 83
Limited access to transcranial Doppler screening and stroke prevention for children with sickle cell disease in Europe: Results of a multinational EuroBloodNet survey 80
Manual erythroexchange in sickle cell disease: multicenter validation of a protocol predictive of volume to exchange and hemoglobin values 79
Will the changing therapeutic landscape meet the needs of patients with sickle cell disease? 74
Inflammatory and senescence-associated mediators affect the persistence of humoral response to COVID-19 mRNA vaccination in transfusion-dependent beta-thalassemic patients 72
Thalassemias and Sickle Cell Diseases in Pregnancy: SITE Good Practice 69
FERTILITY AND PREGNANCY. In: Taher AT, Farmakis D, Porter JB, Cappellini MD, Musallam KM, eds. Guidelines for the Management of Transfusion-Dependent β-Thalassaemia (TDT). 5th ed. Nicosia, Cyprus: Thalassaemia International Federation; 2025. 60
Oxford Hip and Shoulder Scores as Potential Tools for the Early Detection of Avascular Necrosis in Apparently Unaffected Sites in Sickle Cell Disease: Results from a Prospective Cohort Study 58
GROWTH ABNORMALITIES, ENDOCRINE, AND BONE DISEASE 55
The phenotypes of sickle cell disease: strategies to aid the identification of undiagnosed patients in the Italian landscape 49
Incorporating national disease burden in GBD estimates of haemoglobinopathies in Italy 36
Corrigendum to "Characterisation of transfusion-dependent prediabetes using continuous glucose monitoring: The Haemoglycare study" [Diab. Res. Clin. Pract. 222 (2025) 112076] 34
Oxford Hip and Shoulder Scores as Potential Tools for the Early Detection of Avascular Necrosis in Apparently Unaffected Sites in Sickle Cell Disease: Results from a Prospective Cohort Study 23
Myocardial iron is strongly associated with reproductive function in beta-thalassemic women under chelation therapy 22
Totale 11.806
Salva come PNG Salva come JPEG
Categoria #
all - tutte 41.149
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.149
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022444 0 0 0 9 125 31 40 21 23 21 35 139
2022/2023974 103 26 28 60 129 77 0 52 454 10 19 16
2023/2024356 30 14 14 18 132 39 2 10 4 3 28 62
2024/20251.432 10 10 10 44 212 163 244 170 223 110 129 107
2025/20266.144 234 283 332 303 556 3.327 272 269 237 184 104 43
2026/20271.379 155 232 482 510 0 0 0 0 0 0 0 0
Totale 11.832